We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 452

Silicon Valley companies welcome new USPTO outpost

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 18 2013

The U.S. Patent and Trademark Office (USPTO) has begun hiring judges who will staff its Silicon Valley regional office and expects to eventually hire

Biopharmaceuticals to collaborate on cancer drug discovery

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

FORMA Therapeutics Holdings, LLC has reportedly entered a strategic collaboration agreement with Celgene Corp. to discover, develop and commercialize

House passes FDA funding bill

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 7 2012

The U.S. House of Representatives approved legislation (H.R. 5651) on May 30, 2012, that, among other things, would revise and extend the user fees that industry pays the Food and Drug Administration (FDA) to expedite safety reviews of new medicines and medical devices

Hundreds of rare disease treatments in U.S. development pipeline

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 17 2013

A new report from the Pharmaceutical Researchers and Manufacturers of America (PhRMA) claims that 452 medicines and vaccines to address rare diseases

Patent lawsuit reform bill garners wide support

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 31 2013

A U.S. House bill titled the "Innovation Act" (H.R. 3309) has support from both sides of the political aisle and in the business community

IOM publishes report on the effects of falsified and substandard medicines

  • Shook Hardy & Bacon LLP
  • -
  • Global, USA
  • -
  • February 21 2013

At the request of the U.S. Food and Drug Administration (FDA), national think tank the Institute of Medicine (IOM) has published a report that

Primus Green Energy raises $12 million for demonstration plant

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 29 2012

Biofuel company Primus Green Energy Inc. has completed a third round of funding by raising $12 million from IC Green Energy Ltd., the renewable energy arm of Israel Corp. Ltd

NASA tests plant-based biofuel in jets

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

National Aeronautics and Space Administration (NASA) researchers recently concluded a series of test flights in California to study the effects of

USPTO adopts final rule on micro entity status under AIA reduced patent fee provisions

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • January 10 2013

The U.S. Patent and Trademark Office (USPTO) has adopted a final rule that implements the micro entity provision of the Leahy-Smith America Invents Act

Sanctions imposed on counsel in patent litigation affirmed

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 2 2012

The Federal Circuit Court of Appeals has upheld nearly $44,000 in sanctions imposed on the attorney for a plaintiff in patent litigation, finding that he was equally responsible for his client’s failure to adequately respond to an interrogatory seeking its infringement theory